Zepp Health Corporation (ZEPP)

NYSE: ZEPP · USD

$2.35

-0.06 (-2.5%)· Recorded snapshot

Market cap	34.5M
Revenue (ttm)	276M
Net income (ttm)	-43.6M
EPS (ttm)	-$2.79
Shares out	14.7M
Volume	109,990
Beta	1.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 276M
Net income (ttm): -43.6M
EPS (ttm): -$2.79
Market cap: 34.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-21.2

P25 n/aP50 n/aP75 n/a

ROIC-13.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ZEPP indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001720446
Company name	Zepp Health Corporation
Country	Netherlands
Country code	US
CUSIP number	98945L204
Earnings date	2026-11-10
Earnings time	amc
Employees	763
Employees change	-2
Employees growth	-0.26%
Enterprise value	$99.1M
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
Industry	Consumer Electronics
Is primary listing	Yes
Is SPAC	No
ISIN number	US98945L2043
Last 10-K release date	2026-04-24
Last earnings date	2026-09-01
Last refreshed	2026-10-28
Last stock split date	2024-09-16
Last stock split type	Reverse
Market cap	$34.5M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$2.35
Price currency	USD
Sector	Technology
SIC code	3571
Stock price date	2026-10-28
Symbol	ZEPP
Website	https://www.zepp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-118.61%
EV/Sales	0.36x
FCF / EV yield	-26.21%
FCF yield	-74.15%
Industry forward P/E	38.02x
Industry P/E	41.16x
P/B ratio	0.21x
P/S ratio	0.13x
Price / tangible book value	0.22x
Sector forward P/E	18.55x
Sector P/E	32.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-12.59%
EBITDA margin	-11.03%
Gross margin	38.58%
Operating margin	-12.59%
Pretax margin	-14.87%
Profit margin	-15.78%
Profit per employee	$-57,090
Revenue per employee	$361,764
ROA	-3.92%
ROA (5Y)	-2.97%
ROCE	-14.17%
ROE	-21.23%
ROE (5Y)	-11.28%
ROIC	-13.37%
ROIC (5Y)	-8.66%
Tax / revenue	0.91%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	41.96%
Gross profit growth (Q)	10.41%
Gross profit growth 3Y	3.44%
Gross profit growth 5Y	-14.4%
Net income growth years	1
Revenue growth	38.05%
Revenue growth (Q)	6.93%
Revenue growth (QoQ)	23.24%
Revenue growth 3Y	-17.55%
Revenue growth 5Y	-24.34%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-516,000
Depreciation and amortization	$4.3M
EBIT	$-34.8M
EBITDA	$-30.5M
EPS	$-2.79
FCF per share	$-1.79
Free cash flow	$-26.2M
Gross profit	$106.5M
Income taxes	$2.5M
Net income	$-43.6M
Operating income	$-34.8M
Revenue	$276M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.68
Book value per share	$11.68
Debt / equity	0.73
Goodwill	$9.6M
Interest coverage	-5.41
Long-term assets	$277.2M
Long-term liabilities	$60.3M
Net cash (debt)	$-64.6M
Net cash / market cap	-182.91%
Net debt / equity	0.35
Piotroski F-Score	3
Property, plant and equipment	$7.6M
Shareholders' equity	$185M
Tangible book value	$162.6M
Tangible book value per share	$10.27
Total assets	$559.7M
Total cash	$69.7M
Total debt	$134.3M
Total liabilities	$374.7M
WACC	5.95%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	$282.5M
Current liabilities	$314.4M
Current ratio	0.9
Inventory turnover	2.38
Net working capital	$-24.7M
Quick ratio	0.48
Working capital	$-31.9M
Working capital turnover	-71.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.04%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.40
Shareholder yield	1.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$7.14
1D price change	-2.49%
1M price change	-43.24%
1M total return	-43.24%
1W price change	-14.86%
1W total return	-14.86%
1Y price change	-94.89%
1Y return CAGR	-94.9%
1Y total return	-94.89%
20-day SMA	$3.24
200-day SMA	$10.37
3M price change	-51.75%
3M total return	-51.75%
3Y price change	-41.44%
3Y return CAGR	-16.33%
3Y total return	-41.44%
50-day SMA	$4.08
50-day SMA vs 200-day SMA	50under200
52-week high	$46.19
52-week high date	2025-10-28
52-week low	$2.23
52-week low date	2026-10-20
5Y price change	-93.18%
5Y return CAGR	-41.24%
5Y total return	-92.99%
6M price change	-86.09%
6M total return	-86.09%
All-time high	$81.00
All-time high date	2021-02-19
All-time low	$2.06
All-time low date	2024-08-05
Average true range (ATR)	$0.27
Average volume	49.2K
Beta (1Y)	2.42
Beta (2Y)	1.25
Beta (5Y)	1.81
Change from 52-week high	-94.91%
Change from 52-week low	5.38%
Change from all-time high	-97.1%
Change from all-time low	14.08%
Change from open	-4.08%
Day's gap	1.66%
Dollar volume	$258,477
High price	$2.46
Low price	$2.35
Monthly RSI	40.21
Open price	$2.45
Position in 52-week range	0%
Premarket change	0%
Premarket close	$2.41
Premarket price	$2.41
Previous close	$2.41
Price vs 150-day SMA	-67.1%
Price vs 20-day SMA	-27.49%
Price vs 200-day SMA	-77.34%
Price vs 50-day SMA	-42.43%
Relative volume	2.29
RSI	12.83
Sharpe ratio	-2.42
Sharpe ratio (3Y)	0.33
Sharpe ratio (5Y)	-0.15
Sortino ratio	-2.99
Sortino ratio (3Y)	0.64
Sortino ratio (5Y)	-0.18
Volume	110K
Weekly RSI	28.25
YTD price change	-91.28%
YTD total return	-91.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6.1M
Float percentage	41.8%
Shares change (QoQ)	-0.23%
Shares change (YoY)	-1.04%
Shares held by insiders	35.38%
Shares held by institutions	15.44%
Shares outstanding	14.7M
Short % of shares	5.44%
Short ratio	7.3 days

Deeper analysis on ZEPP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ZEPP report

Is a complete ZEPP research report available?

No complete published report is available for Zepp Health Corporation (ZEPP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Zepp Health Corporation (ZEPP)

Price

Financial snapshot

Fair-value bridge

Latest news · ZEPP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZEPP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ZEPP

Frequently asked questions